ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 21 filers reported holding ELIEM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,785 | -28.3% | 12,806 | -22.7% | 0.00% | 0.0% |
Q2 2023 | $45,733 | -12.7% | 16,570 | -10.5% | 0.00% | -33.3% |
Q1 2023 | $52,412 | -15.4% | 18,520 | +1.9% | 0.00% | -25.0% |
Q4 2022 | $61,936 | +12.6% | 18,179 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $55,000 | -26.7% | 18,179 | -23.2% | 0.00% | -20.0% |
Q2 2022 | $75,000 | -7.4% | 23,665 | +6.6% | 0.01% | -16.7% |
Q1 2022 | $81,000 | -19.0% | 22,209 | +77.9% | 0.01% | -14.3% |
Q4 2021 | $100,000 | – | 12,486 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 1,938,263 | $5,097,632 | 4.68% |
RA Capital Management | 13,150,849 | $34,586,733 | 0.68% |
SILVERARC CAPITAL MANAGEMENT, LLC | 121,110 | $318,519 | 0.10% |
Atom Investors LP | 78,886 | $207,470 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 811,680 | $2,134,718 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 55,223 | $145,789 | 0.00% |
Chicago Partners Investment Group LLC | 12,806 | $32,785 | 0.00% |
TUDOR INVESTMENT CORP ET AL | 29,704 | $78,122 | 0.00% |
NORTHERN TRUST CORP | 11,182 | $29,409 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |